Flavor and fragrance producer IFF (NYSE: IFF) announced better-than-expected revenue in Q1 CY2026, but sales fell by 3.6% year on year to $2.74 billion. On the other hand, the company’s full-year revenue guidance of $10.65 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP profit of $1.25 per share was 16.5% above analysts’ consensus estimates.

Is now the time to buy IFF? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

International Flavors & Fragrances’ first quarter results were met with a strong positive market reaction, as management credited broad-based volume growth across all business units and disciplined execution on productivity initiatives. CEO Erik Fyrwald highlighted that the company’s Health & Biosciences segment led with mid-single-digit sales growth, while Taste, Food Ingredients, and Scent also posted gains, supported by improved operational focus and a simplified portfolio. CFO Michael DeVeau emphasized that operational improvements and working capital discipline contributed to significantly higher free cash flow compared to the prior year.

Looking ahead, management’s reaffirmed full-year guidance is shaped by their expectation that productivity gains, robust innovation pipelines, and incremental pricing actions will help counter inflationary pressures. CEO Erik Fyrwald stated, “We are investing for the future—in innovation, commercial, and supply chain capabilities, and in customer partnerships that matter most.” However, management acknowledged ongoing uncertainty from geopolitical risks and input cost inflation, but remains confident that continued commercial execution and innovation-driven growth will keep the company within its forecasted revenue and profit ranges.

Key Insights from Management’s Remarks

Management attributed first quarter performance to volume-led growth in all segments, successful productivity initiatives, and early benefits from portfolio simplification, while also addressing evolving inflationary and geopolitical headwinds.

• Health & Biosciences momentum: The Health & Biosciences segment delivered mid-single-digit sales growth, with management citing strong demand in animal nutrition and food biosciences. Investments in regional production and R&D, such as the enzyme facility in Argentina and a new application lab in Brazil, were highlighted as enablers of this growth.
• Taste segment profitability: The Taste segment showed notable profitability improvement, driven by volume growth, favorable pricing, and ongoing productivity efforts. Management noted that the team’s discipline in operational efficiency and pricing initiatives contributed to an 18% increase in segment profitability versus the prior year.
• Food Ingredients divestiture progress: IFF completed the sale of its commodity soy crush, concentrates, and lecithin business and reported that the broader Food Ingredients divestiture process is advancing, with strong buyer interest and expectations for updates next quarter.
• Scent business headwinds: While Fine Fragrance and Consumer Fragrance saw growth, management called out ongoing pressure in the commodity portion of Fragrance Ingredients due to price competition and soft demand, especially from Indian and Chinese competitors. The company is de-emphasizing external sales of these commodity ingredients.
• Productivity and cash flow focus: Management credited ongoing cost discipline and working capital improvements for a significant year-over-year increase in free cash flow, reinforcing a focus on productivity as a key lever for supporting profitability in a volatile cost environment.

Drivers of Future Performance

IFF’s outlook for the rest of the year is anchored by expectations for improved productivity, innovation-led growth, and pricing actions to offset inflation, though management cited ongoing geopolitical and input cost risks.

• Inflation offset through pricing: Management expects continued logistics, energy, and raw material inflation, with price increases and surcharges being implemented to offset these pressures over the course of the year. CFO Michael DeVeau described these pricing actions as modest initially, but building as input cost inflation flows through.
• Portfolio simplification and reinvestment: The ongoing divestiture of the Food Ingredients business is expected to further focus IFF on higher-growth, higher-margin segments. Proceeds from the sale will be used to maintain leverage targets, fund organic investments, and pursue bolt-on acquisitions or ventures with strong return profiles.
• Innovation and commercial pipeline strength: Management cited a robust pipeline of new products and commercial wins across key segments, especially in Health & Biosciences and Taste. CEO Erik Fyrwald expressed confidence that these pipelines will support growth, particularly as headwinds in commodity Scent Ingredients abate and new launches materialize later this year and into 2027.

Catalysts in Upcoming Quarters

Looking ahead, the StockStory team will be tracking (1) the successful implementation of pricing actions to offset inflation, (2) progress on the Food Ingredients divestiture and how proceeds are reinvested, and (3) the pace at which innovation pipelines in Health & Biosciences and Scent begin to translate into commercial wins. The evolution of input cost trends and geopolitical impacts will also be important to watch.

International Flavors & Fragrances currently trades at $82.93, up from $70.77 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.